Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dispel that old myth

A Bagust1

  • 1York Health Economics Consortium.

The Health Service Journal
|June 12, 1990
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)·2015
Same author

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)·2013
Same author

Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis.

Health technology assessment (Winchester, England)·2011
Same author

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Health technology assessment (Winchester, England)·2011
Same author

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.

Health technology assessment (Winchester, England)·2010
Same author

Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.

Health technology assessment (Winchester, England)·2010
Same journal

Clouds, Silver Linings and Storm Desmond.

The Health service journal·2018
Same journal

Time to Nurture Better Services.

The Health service journal·2018
Same journal

Let Patient Experience Take Centre Stage.

The Health service journal·2018
Same journal

First Do No Harm.

The Health service journal·2018
Same journal

Sepsis Faces a New Front.

The Health service journal·2018
Same journal

Back to the Drawing Board.

The Health service journal·2018
See all related articles